As of 5 Jul 2026, BRAWN BIOTECH LTD. share price is ₹19.75. The stock opened at ₹18.80, compared to its previous close of ₹19.70. During today's trading session, BRAWN BIOTECH LTD. share price moved in the range of ₹18.80 to ₹19.75, with an average price of ₹19.27 for the day. Looking at its last 52-week, the stock has touched a low of ₹16.66 and a high of ₹24.37.
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
| Particulars | Mar 2023 |
|---|---|
| Revenue | 0.72 |
| Operating profit | 0.22 |
| Net profit | 0.19 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹13.46 | ₹16.49 | ₹22.23 | ₹8.62 |
| Other Income | ₹0.09 | ₹0.09 | ₹0.01 | ₹0.00 |
| Total Revenue | ₹13.56 | ₹16.58 | ₹22.24 | ₹8.62 |
| Total Expenses | ₹15.36 | ₹18.13 | ₹22.65 | ₹10.74 |
| Profit Before Tax | -₹1.80 | -₹1.54 | -₹0.41 | -₹2.12 |
| Tax | -₹0.06 | -₹0.30 | ₹0.46 | -₹0.47 |
| Profit After Tax | -₹1.74 | -₹1.25 | -₹0.87 | -₹1.64 |
| EPS - Basic | -₹5.68 | -₹4.15 | -₹3.04 | -₹5.48 |
| EPS - Diluted | -₹5.68 | -₹4.15 | -₹3.04 | -₹5.48 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | -₹1.80 | -₹1.54 | -₹0.41 | -₹2.12 |
| Income before WC changes | -₹1.64 | -₹1.49 | -₹0.34 | -₹1.93 |
| Change in Assets | -₹5.91 | ₹0.16 | -₹1.01 | ₹0.63 |
| Change in Liabilities | ₹7.60 | ₹1.30 | ₹1.66 | ₹1.49 |
| Change in WC | ₹1.69 | ₹1.46 | ₹0.65 | ₹2.12 |
| Cash flow from Operations | ₹0.05 | -₹0.03 | ₹0.32 | ₹0.19 |
| Cash flow from Investing | -₹0.24 | -₹0.01 | -₹0.10 | -₹0.30 |
| Cash flow from Financing | ₹0.00 | ₹0.00 | -₹0.01 | -₹0.06 |
| Total Cash Flow | -₹0.20 | -₹0.04 | ₹0.21 | -₹0.17 |
| Cash (Start of the year) | ₹0.40 | ₹0.44 | ₹0.22 | ₹0.40 |
| Cash (End of the year) | ₹0.20 | ₹0.40 | ₹0.44 | ₹0.22 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹2.99 | ₹1.45 | ₹1.13 | ₹1.60 |
| Current Assets | ₹17.50 | ₹13.14 | ₹13.40 | ₹12.19 |
| Total Assets | ₹20.49 | ₹14.59 | ₹14.53 | ₹13.78 |
| Current Liabilities | ₹9.33 | ₹6.51 | ₹8.05 | ₹6.32 |
| Net Current Asset | ₹8.17 | ₹6.63 | ₹5.35 | ₹5.87 |
| Non-Current Liabilities | ₹7.80 | ₹3.02 | ₹0.17 | ₹0.24 |
| Equity Capital | ₹3.36 | ₹5.07 | ₹6.31 | ₹7.22 |
| Total Equity & Liabilities | ₹20.49 | ₹14.59 | ₹14.53 | ₹13.78 |
Brawn Biotech Limited is an India-based integrated healthcare company. The Company's pharmaceutical products cover all product segments, such as Antibacterials, Cardiovasculars, Antidiabetics, Analgesics, Gastrointestinal, Antifungals, Skin Care, Antipsychotics, Antiasthmatics, Antacids, Antimalarials, And Nutritionals. Its products include Sefix-400 Capsules, Sefix-200 Capsules, Celevran Cream W/C (25GM), Voltran Gel W/C (25GM), Folic Acid Tablets 8P 5MG, Ponstran Capsules 250MG, Fugeran Cream W/C (15GM), Stopin Tablets, Cefixime Tablets 100MG (110), Cefixime Tablets USP 200MG (110), Carbramazepine 200 MG IP Tab, Potassium Chloride for Injection 15% 150mg/ml USP (10 ML), Promethazine HCL Injection 25 MG/ML, Allopurinol 100mg IP Tab, Carbamazepine 100 mg IP Tab, Feme Tab, Bromex Liquid, Salbutamol 4 mg IP Tab, Chlorpheniramine Maleate 4mg Tab, Pheniramine Maleate 25mg Tab, Eracef 500 mg, Erazide 1 Gm Injection, Hyoscine Butyl Bromide (1 ml) IP Inj, Alprazolam 0.5 Mg Tab, and others.
BRAWN BIOTECH LTD. share price is ₹19.75 as on 03 Jul, 2026, 15:15 IST.
In the last 1 year, BRAWN BIOTECH LTD. delivered a return of -1.25%. The BRAWN BIOTECH LTD. share price hit a high of ₹24.37 and low of ₹16.66.
The Mutual Fund Shareholding in BRAWN BIOTECH LTD. was 0.35% at the end of Mar 2026.
The 52-week high and low of BRAWN BIOTECH LTD. share is ₹24.37 and ₹16.66 as of 03 Jul, 2026.
The market capitalisation of BRAWN BIOTECH LTD. is ₹5.91 Crores as on 03 Jul, 2026.
The stock symbol of BRAWN BIOTECH LTD. is 530207 on the BSE, and the ISIN is INE899B01015.
BRAWN BIOTECH LTD. shares closed yesterday at ₹19.70 on BSE
To buy BRAWN BIOTECH LTD. shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
No, shares of BRAWN BIOTECH LTD. or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell BRAWN BIOTECH LTD. shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
The PE and PB ratio of BRAWN BIOTECH LTD. is 6.27 and 1.36 respectively, as on 03 Jul, 2026, 15:15 IST.